As of 2026-10-02, the Relative Valuation of Sana Biotechnology Inc (SANA) is (19.98) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.89 USD, the upside of Sana Biotechnology Inc based on Relative Valuation is -791.4%.
The range of the Relative Valuation is (19.96) - (21.77) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 25.3x - 28.6x | 26.2x |
| Forward P/E multiples | 26.2x - 29.2x | 26.3x |
| Fair Price | (19.96) - (21.77) | (19.98) |
| Upside | -790.6% - -853.3% | -791.4% |
| Date | P/E |
| 2026-10-02 | -3.77 |
| 2026-10-01 | -3.80 |
| 2026-09-30 | -3.83 |
| 2026-09-29 | -3.82 |
| 2026-09-28 | -3.85 |
| 2026-09-25 | -3.87 |
| 2026-09-24 | -3.89 |
| 2026-09-23 | -4.05 |
| 2026-09-22 | -4.37 |
| 2026-09-21 | -4.07 |
| 2026-09-18 | -4.07 |
| 2026-09-17 | -4.07 |
| 2026-09-16 | -3.84 |
| 2026-09-15 | -4.15 |
| 2026-09-14 | -4.20 |
| 2026-09-11 | -4.11 |
| 2026-09-10 | -4.06 |
| 2026-09-09 | -4.16 |
| 2026-09-08 | -4.53 |
| 2026-09-04 | -5.06 |
| 2026-09-03 | -5.15 |
| 2026-09-02 | -5.11 |
| 2026-09-01 | -5.03 |
| 2026-08-31 | -5.08 |
| 2026-08-28 | -5.16 |
| 2026-08-27 | -5.37 |
| 2026-08-26 | -5.47 |
| 2026-08-25 | -5.39 |
| 2026-08-24 | -4.97 |
| 2026-08-21 | -5.14 |
| 2026-08-20 | -4.91 |
| 2026-08-19 | -5.39 |
| 2026-08-18 | -4.77 |
| 2026-08-17 | -4.83 |
| 2026-08-14 | -4.66 |
| 2026-08-13 | -4.82 |
| 2026-08-12 | -4.95 |
| 2026-08-11 | -4.98 |
| 2026-08-10 | -4.74 |
| 2026-08-07 | -4.62 |
| 2026-08-06 | -4.48 |
| 2026-08-05 | -4.61 |
| 2026-08-04 | -4.47 |
| 2026-08-03 | -4.18 |
| 2026-07-31 | -4.11 |
| 2026-07-30 | -4.27 |
| 2026-07-29 | -4.16 |
| 2026-07-28 | -4.32 |
| 2026-07-27 | -4.31 |
| 2026-07-24 | -4.18 |